UB Paderborn / Katalog / Suche / in CDI

Proteinaceous cysteine protease inhibitors

Cellular and molecular life sciences : CMLS, 2005-03, Vol.62 (6), p.653-669, Article 653

Dubin, G

2005

Volltextzugriff (PDF)

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

The Lancet (British edition), 2009-07, Vol.374 (9686), p.301-314

2009

Volltextzugriff (PDF)

Extracellular Proteases of Staphylococcus spp

Biological chemistry, 2002-07, Vol.383 (7-8), p.1075-1086

Dubin, Grzegorz

2002

Volltextzugriff (PDF)

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years

The Lancet (British edition), 2009-12, Vol.374 (9706), p.1975-1985

2009

Volltextzugriff (PDF)

Long‐term outcomes following impedance‐controlled radiofrequency ablation for the treatment of chronic rhinitis

Laryngoscope investigative otolaryngology, 2024-06, Vol.9 (3), p.e1286-n/a

2024

Volltextzugriff (PDF)

Clinical evaluation of a novel multipoint radiofrequency ablation device to treat chronic rhinitis

Laryngoscope investigative otolaryngology, 2023-04, Vol.8 (2), p.367-372

2023

Volltextzugriff (PDF)

Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18

International journal of cancer, 2012-07, Vol.131 (1), p.106-116

2012

Volltextzugriff (PDF)

PO-432 Small molecules, peptides and antibodies – the comparison of PD-1/PD-L1 blocking potential in an in vitro immune checkpoint blockade assay

ESMO open, 2018-07, Vol.3 (Suppl 2), p.A400-A400

2018

Volltextzugriff (PDF)

Safety and Immunogenicity of Glycoprotein D—Adjuvant Genital Herpes Vaccine

Clinical infectious diseases, 2005-05, Vol.40 (9), p.1271-1281

2005

Volltextzugriff (PDF)

The potential epidemiological impact of a genital herpes vaccine for women

Sexually transmitted infections, 2004-02, Vol.80 (1), p.24-29

2004

Volltextzugriff (PDF)

Molecular cloning and biochemical characterisation of proteases from Staphylococcus epidermidis

Biological chemistry, 2001-11, Vol.382 (11), p.1575-1582

2001

Volltextzugriff (PDF)

Preservation of Natural Frontal Sinus Outflow in the Management of Frontal Sinus Osteomas

Otolaryngology-head and neck surgery, 2006, Vol.134 (1), p.18-24

2006

Volltextzugriff (PDF)

Radiographic resolution of chronic rhinosinusitis without polyposis after 6 weeks vs 3 weeks of oral antibiotics

Annals of allergy, asthma, & immunology, 2007, Vol.98 (1), p.32-35

2007

Volltextzugriff (PDF)

Treatment of Chronic Maxillary Atelectasis Using Balloon Dilation

Otolaryngology-head and neck surgery, 2013-11, Vol.149 (5), p.782-785

2013

Volltextzugriff (PDF)

Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied

The Journal of infectious diseases, 2020-08, Vol.222 (6), p.948-956

2020

Volltextzugriff (PDF)

Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

The Lancet (British edition), 2006-04, Vol.367 (9518), p.1247-1255

2006

Volltextzugriff (PDF)

Gender‐neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III)

International journal of cancer, 2018-11, Vol.143 (9), p.2299-2310

2018

Volltextzugriff (PDF)

Endoscopic Modified Lothrop (Draf III) with Frontal Sinus Punches

The Laryngoscope, 2005-09, Vol.115 (9), p.1702-1703

2005

Volltextzugriff (PDF)

Evaluation of HPV type‐replacement in unvaccinated and vaccinated adolescent females—Post‐hoc analysis of a community‐randomized clinical trial (II)

International journal of cancer, 2018-06, Vol.142 (12), p.2491-2500

2018

Volltextzugriff (PDF)

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

The Lancet (British edition), 2004-11, Vol.364 (9447), p.1757-1765

2004

Volltextzugriff (PDF)

Clear cell odontogenic carcinoma: A comprehensive analysis of treatment strategies

Head & neck, 2005-06, Vol.27 (6), p.536-542

2005

Volltextzugriff (PDF)

O638 Cervarix® induces higher HPV-16/18-specific T cell responses compared to Gardasil ® in healthy women aged 18–45 years

International journal of gynecology and obstetrics, 2009-10, Vol.107 (S2), p.S274-S275

2009

Volltextzugriff (PDF)

Impact of gender‐neutral or girls‐only vaccination against human papillomavirus—Results of a community‐randomized clinical trial (I)

International journal of cancer, 2018-03, Vol.142 (5), p.949-958

2018

Volltextzugriff (PDF)

Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials

BMJ open, 2017-08, Vol.7 (8), p.e015867-e015867

2017

Volltextzugriff (PDF)

Characterisation of a highly specific, endogenous inhibitor of cysteine protease from Staphylococcus epidermidis, a new member of the staphostatin family

Biological chemistry, 2004-06, Vol.385 (6), p.543-546

2004

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Proteinaceous cysteine protease inhibitors

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Extracellular Proteases of Staphylococcus spp

Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years

Long‐term outcomes following impedance‐controlled radiofrequency ablation for the treatment of chronic rhinitis

Clinical evaluation of a novel multipoint radiofrequency ablation device to treat chronic rhinitis

Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18

PO-432 Small molecules, peptides and antibodies – the comparison of PD-1/PD-L1 blocking potential in an in vitro immune checkpoint blockade assay

Safety and Immunogenicity of Glycoprotein D—Adjuvant Genital Herpes Vaccine

The potential epidemiological impact of a genital herpes vaccine for women

Molecular cloning and biochemical characterisation of proteases from Staphylococcus epidermidis

Preservation of Natural Frontal Sinus Outflow in the Management of Frontal Sinus Osteomas

Radiographic resolution of chronic rhinosinusitis without polyposis after 6 weeks vs 3 weeks of oral antibiotics

Treatment of Chronic Maxillary Atelectasis Using Balloon Dilation

Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied

Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Gender‐neutral vaccination provides improved control of human papillomavirus types 18/31/33/35 through herd immunity: Results of a community randomized trial (III)

Endoscopic Modified Lothrop (Draf III) with Frontal Sinus Punches

Evaluation of HPV type‐replacement in unvaccinated and vaccinated adolescent females—Post‐hoc analysis of a community‐randomized clinical trial (II)

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

Clear cell odontogenic carcinoma: A comprehensive analysis of treatment strategies

O638 Cervarix® induces higher HPV-16/18-specific T cell responses compared to Gardasil ® in healthy women aged 18–45 years

Impact of gender‐neutral or girls‐only vaccination against human papillomavirus—Results of a community‐randomized clinical trial (I)

Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials

Characterisation of a highly specific, endogenous inhibitor of cysteine protease from Staphylococcus epidermidis, a new member of the staphostatin family

Suchergebnisse filtern